DexCom, Inc.

NASDAQ:DXCM

84.67 (USD) • At close May 9, 2025
Bedrijfsnaam DexCom, Inc.
Symbool DXCM
Munteenheid USD
Prijs 84.67
Beurswaarde 33,199,699,690
Dividendpercentage 0%
52-weken bereik 57.52 - 132.26
Industrie Medical Devices
Sector Healthcare
CEO Mr. Kevin Ronald Sayer
Website https://www.dexcom.com

An error occurred while fetching data.

Over DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an

Vergelijkbare Aandelen

Biogen Inc. logo

Biogen Inc.

BIIB

118.17 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

491.7 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

33.15 USD

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.22 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

181.88 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

75.83 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)